BJH - volume 12, issue 8, december 2021
N. Meuleman MD, PhD, J. Caers MD, PhD, K. Fostier MD, P. Vlummens MD, S. Pans MD, L. Goethals MD, PhD, J. Alexiou MD, M. Cliquennois MD, C. Doyen MD, A. de Weweire MD, R. Schots MD, PhD, M. Delforge MD, PhD, M.C. Vekemans MD
Despite major improvements in the diagnosis and treatment of multiple myeloma (MM), bone damage remains a major feature of this disease. With the development of new diagnostic tools, conventional skeletal studies have been progressively replaced by novel imaging techniques. Today, imaging plays a crucial role in defining symptomatic multiple myeloma, measurement of the extent of skeletal involvement and assessing therapeutic response including minimal residual disease (MRD). Based on an extensive review of the recent literature, we propose an array of Belgian recommendations for myeloma imaging to be used as a reference by haematologists in their daily practice.
(BELG J HEMATOL 2021;12(8):338–43)
Read moreBJH - volume 11, issue Abstract Book BHS, february 2020
E. Janssens , dr. J. Van Dorpe , V. Van Hende MD, I. Moors MD, P. Vlummens MD, C. De Vriendt
BJH - volume 11, issue Abstract Book BHS, february 2020
C. Muylaert , E. De Bruyne , P. Vlummens MD, dr. K. Maes , K. De Veirman , E. Menu , K. Vanderkerken PhD
BJH - volume 11, issue Abstract Book BHS, february 2020
F. Verbeke , P. Decruyenaere , P. Vlummens MD, A. Vantilborgh , K. Devreese
BJH - volume 11, issue Abstract Book BHS, february 2020
K. Voet , dr. J. Van Dorpe , P. Vlummens MD, D. Mazure MD
BJH - volume 11, issue Abstract Book BHS, february 2020
E. De Backer MD, P. Vlummens MD, R. Callens MD, I. Moors MD
BJH - volume 11, issue Abstract Book BHS, february 2020
dr. K. Maes , A. Vantilborgh , P. Vlummens MD
Top
